FDA approves Alhemo® injection as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B with inhibitors PressReach · Dec 21, 2024
YolTech Therapeutics Announces Successful Completion of Dose Escalation Phase in Phase I Trial of YOLT-201 for ATTR PressReach · Dec 21, 2024
Walnuts are a "Healthy" Food According to the U.S. Food & Drug Administration PressReach · Dec 21, 2024
Florida Blue Foundation Awards Multi-Year Grant to Common Threads to Combat Food Insecurity in Miami PressReach · Dec 21, 2024
Cosmoplastic Surgery and Cosmetic Physician Partners Collaborate to Enhance Patient-Centered Care PressReach · Dec 20, 2024
Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Applied Therapeutics, Inc. PressReach · Dec 20, 2024
MemorialCare Orange County Entities Named on The Orange County Register's 2024 Top Workplaces List PressReach · Dec 20, 2024
Prytime Medical Announces Key Prolonged REBOA Advancements to Treat Maternal Hemorrhage PressReach · Dec 20, 2024
StemCyte Announces Successful Phase IIa Clinical Trial Results for HPC, Cord Blood in Treating Post-COVID Syndrome: 85% of Patients Experience Complete Relief from Fatigue Symptoms PressReach · Dec 20, 2024
Implantica strengthens the strategic RefluxStop™ expansion with the addition of yet another key University Hospital in Germany with several more in the pipeline PressReach · Dec 19, 2024
Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete PressReach · Dec 19, 2024
